Kite's Yescarta First CAR T-cell Therapy to Receive European Marketing Authorization for Use in Second-Line Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma Pharmaceutical Investing
Medtronic First to Receive FDA Approval for Pacing the Heart's Natural Conduction System Medical Device Investing
AbbVie Vice Chairman of External Affairs and Chief Legal Officer Laura J. Schumacher to Retire Pharmaceutical Investing
Gilead and MacroGenics Announce Oncology Collaboration to Develop Bispecific Antibodies Pharmaceutical Investing
IARPA, Ginkgo Bioworks and Draper Announce New Technologies to Detect Engineered DNA Life Science Investing
Silo Wellness Closes Acquisition of Dyscovry Science and Its Psilocybin Pharmaceutical Biosynthesis and Research Portfolio Psychedelics Investing
Medtronic to webcast renal denervation investor & analyst briefing on November 7 Medical Device Investing
Gilead Sciences to Release Third Quarter 2022 Financial Results on Thursday, October 27, 2022 Pharmaceutical Investing
Marvel Biosciences Signs Letter of Intent with Novatech for Phase 1 Trial of MB-204 and Provides Corporate Update
